Indegene Limited is a digital-first life sciences commercialization company focusing on enabling biopharmaceutical and medical device companies to develop and launch products more efficiently. Their core areas are digital marketing operations, medical, and regulatory operations.

Indegene has embraced Generative AI through its Cortex platform, deploying AI-driven applications to enhance efficiency and effectiveness in life sciences operations, indicating a commitment to leveraging cutting-edge technology for client solutions.

Recent strategic acquisitions, such as BioPharm and WARN & Co, enhance Indegene’s capabilities in targeting specialized healthcare markets and consulting, notably expanding their global reach and service offerings.

Capacity expansion with new centers in Hyderabad, Spain, and London, aimed at scaling operations and supporting an AI-first approach, underscores Indegene's strategic focus on geographical and service enhancement.

Indegene is capitalizing on strategic partnerships with hyperscalers to advance their GenAI solutions, reinforcing their market position as a pioneer in digital transformation for the life sciences industry.